APGE Financials

Apogee Therapeutics Inc - Financial statements & key metrics

Stock Price

$74.68

Market Cap

$5.19B

0

EPS

$-4.22

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

-

Gross Profit

-

Operating Income

-

Net Income

$-182.15M

EPS (Diluted)

$-3.30

Balance Sheet Highlights

Total Assets

$753.95M

Total Liabilities

$37.16M

Shareholders Equity

-

Cash & Equivalents

$141.79M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-171.17M

CapEx

-

Free Cash Flow

-

Profitability Metrics

ROE

-0.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is APGE revenue?

View APGE's income statement for detailed revenue data.

Is APGE profitable?

APGE reported a loss of $182.15M in the most recent quarter.

What is APGE market cap?

APGE has a market capitalization of $5.19B, making it a mid-cap stock.

Does APGE have debt?

View APGE's balance sheet for debt information.

What is APGE cash flow?

Cash flow data is available in the full financial statements.

Explore Categories